Literature DB >> 26450396

Vaccination Using Gene-Gun Technology.

Elke S Bergmann-Leitner1, Wolfgang W Leitner2.   

Abstract

DNA vaccines against infection with Plasmodium have been highly successful in rodent models of malaria and have shown promise in the very limited number of clinical trials conducted so far. The vaccine platform is highly attractive for numerous reasons, such as low cost and a very favorable safety profile. Gene gun delivery of DNA plasmids drastically reduces the vaccine dose and does not only have the potential to make vaccines more accessible and affordable, but also simplifies (a) the testing of novel antigens as vaccine candidates, (b) the testing of antigen combinations, and (c) the co-delivery of antigens with molecular adjuvants such as cytokines or costimulatory molecules. Described in this chapter are the preparation of the inoculum (i.e., DNA plasmids attached to gold particles, coating to the inside of plastic tubing also referred to as gene gun "bullets" or cartridges), the gene gun vaccination procedure, and the challenge of mice with Plasmodium berghei parasites to test the efficacy of the experimental vaccine.

Entities:  

Keywords:  Biolistic vaccine; DNA vaccines; Gene gun; Immunization; Particle-mediated epidermal delivery

Mesh:

Substances:

Year:  2015        PMID: 26450396     DOI: 10.1007/978-1-4939-2815-6_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Development of Cancer Immunotherapies.

Authors:  Diana C DeLucia; John K Lee
Journal:  Cancer Treat Res       Date:  2022

2.  Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination.

Authors:  Felicia Watson; Melanie Shears; Jokichi Matsubara; Anya Kalata; Annette Seilie; Irene Cruz Talavera; Tayla Olsen; Moriya Tsuji; Sumana Chakravarty; B Kim Lee Sim; Stephen Hoffman; Sean Murphy
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 3.707

3.  Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein.

Authors:  Xiangxiang Tian; Yifan Zhang; Zhangyufan He; Shaoshuai Li; Dongmei Yan; Zhaoqin Zhu; Yanmin Wan; Wanhai Wang
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

4.  Single Amino Acid Deletion at N-Terminus of the Target Antigen in DNA Vaccine Induces Altered CD8+ T Cell Responses against Tumor Antigen.

Authors:  Takashi Imai
Journal:  Vaccines (Basel)       Date:  2021-05-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.